Knowledge Content
From the perspective of **core fitness scenarios**, different needs correspond to clear duration boundaries:
https://www.fiercerawsource.com/peptides/premium-high-purity-peptides-aicar-50mg.html
1. **Muscle Gain Support Scenario: 4-6 Week Base Cycle**
Aicar promotes mitochondrial generation in muscle cells by activating AMPK, but long-term activation can create a "mutually exclusive effect" with mTOR (molecular toxin receptor agonist). A daily dose of 500-1000mg, divided into two injections (1 hour before training + before bed), can increase muscle aerobic metabolic efficiency by 30% in 4 weeks, significantly enhancing muscle fiber endurance when combined with resistance training. If extended to 6 weeks, it is necessary to stop taking the medication one day per week to balance AMPK and mTOR activity and avoid a decrease in muscle synthesis efficiency. During this period, while muscle mass doesn't increase dramatically, muscle density and training endurance improve significantly, making it suitable for "sculpted" muscle building needs.
2. **Fat Loss and Body Shaping Scenario: 6-8 Weeks as the Safe Upper Limit**
During the fat loss period, Aicar works by increasing the β-oxidation rate of adipocytes (experiments show an increase of 40%) and inhibiting the activity of fat synthesis enzymes. Daily injections of 800mg, combined with a low-carbohydrate diet, can result in an additional 1.5%-2% reduction in body fat percentage over 6 weeks. If extending to 8 weeks, the dosage should be reduced to 500mg/day from the 7th week onwards, and coenzyme Q10 supplementation (100mg/day) should be used to protect mitochondria and avoid oxidative stress caused by prolonged accelerated metabolism. Note that after 8 weeks, fat breakdown efficiency will drop sharply due to AMPK receptor desensitization, and side effects such as appetite suppression and mild fatigue may occur.
3. **Endurance Enhancement Scenario: Short-Term Sprint 2-3 Weeks Before Competition**
Endurance athletes (such as long-distance runners and cyclists) often use a "short-term high-dose" regimen: 1200mg daily injection for 2 weeks before the competition, which can increase muscle glycogen reserve efficiency by 25% and shift the lactate threshold backward by 10%-15%; 3 days before the competition, the dose is reduced to 500mg to avoid pre-race fatigue due to excessive exertion. This regimen does not require a long-term cycle, as the endurance enhancement effect can be maintained for up to one week after discontinuation, and it avoids the metabolic burden of long-term use.
**Key Principles of Risk Control**:
- **Absolute Contraindication: Continuous use exceeding 10 weeks**
Long-term activation of AMPK interferes with gluconeogenesis (hepatic glucose synthesis), potentially leading to fasting hypoglycemia; it also inhibits cholesterol synthesis, causing a decrease in high-density lipoprotein (good cholesterol), increasing cardiovascular risk.
- **Individual Adjustment**
Those with weak liver or kidney function should shorten the treatment duration by 20%, administering three small injections (e.g., 300mg each in the morning, noon, and evening). If muscle soreness or decreased sleep quality occurs, discontinue use immediately for 3-5 days, and restart at half the dose after symptoms subside.
**Summary**: The core principle of Aicar's treatment duration is "short-term, precise effectiveness"-4-6 weeks for muscle gain, 6-8 weeks for fat loss, and 2-3 weeks for endurance improvement, all requiring a "discontinuation buffer" or "dose gradient adjustment." Its value lies in "metabolic optimization" rather than "direct growth stimulation." Excessively long treatment periods are not only ineffective but can also disrupt the body's metabolic balance. Treatment should be stopped promptly at the "peak effect" point, rather than blindly extending the treatment duration.
